2402 – Prof J.D. van Buul: IMMUNE MODULATION THROUGH THE VASCULATURE:
The innate immune system talks via the endothelium with the adaptive immune system
Budget: € 368.650, Project duration: 4 years
2408 – Prof J. Arens/C. Viseer: Development and validation of artificial blood
Budget: € 449.623 3 years
2412 – Prof G. Vidarsson: Triggers of afucosylated IgG responses
Budget: € 449.900, Project duration: 4 years
2414 – Dr. G. Lugthart: Unravelling the role of bone marrow macrophage and erythroblast interaction in stem cell transplant rejection in β-thalassemia
Budget: € 449.945, Project duration: 4 years
2416 – Dr. I Timmerman: Hijacking of the bone marrow niche by tumor cells: impact on hematopoiesis (HiT-Hema)
Budget: € 698.800, Project duration: 3+2 years
2429 – Prof E.M.E. Verdegaal: CD8-immunoPET guided lesion selection to improve response to adoptive cell therapy
Budget: € 329.235, Project duration: 3 years
ECG-2404 - Dr. Nila H Servaas (Sanquin Research): Deciphering the influence of X Chromosome Inactivation on Sex-Specific Differences in T cell Responses to Cancer Immunotherapy
Budget: € 197.000, Project duration: 2 years
Â
ECG-2405 - Yvonne K Jongejan, MSc (LUMC): Therapeutic small interfering RNAs targeting endothelial von Willebrand factor in von Willebrand disease
Budget: € 200.000, Project duration: 1.5 years
Â
ECG-2410 - Dr. Julia Tilburg (Sanquin Research): Mapping of the cellular heterogeneity of megakaryocytes in the bone marrow
Budget: € 165.000, Project duration: 2 years